Osimertinib
Also known as Tagrisso (us), Osimert (india)
A targeted therapy for certain EGFR-mutation non-small-cell lung cancers.
SMILES: CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC
Based on 30 tablets per month. US $553.43 vs India $2.86 per tablet.
The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.
- Medicine savings over 6 months
- $99,103
- Estimated travel cost
- − $2,300
- Net savings after travel
- $96,803
Even after travel, you could come out ahead by about $96,803.
Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.
Osimertinib is filled about 96.4K times a year under Medicare Part D. At the prices above, that works out to roughly:
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.